Real-world treatment (tx) patterns, cost, and overall survival (OS) by line of therapy among patients (pt) with mantle cell lymphoma (MCL): A SEER-Medicare (SM) analysis.
| Publicado en: | Journal of Clinical Oncology Vol. 40; pp. 19 - 20 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2022 Supplement 28
|
| Acceso en línea: | Ver este registro en EBSCOhost |